Author

H. Grallert

University of Dundee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:GWAS / association mapping· 2 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:GWAS summary statistics· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. Forman· 2 shared A. Fritsche· 2 shared Adem Y. DawediD· 2 shared Amelie Bonneford· 2 shared Andrea MariiD· 2 shared Angus G. JonesiD· 2 shared Anita M. HennigeiD· 2 shared Anubha MahajaniD· 2 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

A. Forman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacogenomics of GLP-1 Receptor Agonists: A genome-wide analysis of observational data and large randomized controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Anand Brown, Timothy James McDonald, Lin Li, Shuaicheng Wang, Mun‐Gwan Hong, Sapna Sharma, Neil R. Robertson, Anubha Mahajan, Xuan Wang, Mark Walker, Stephen Charles Langford Gough, Leen M. ‘t Hart, Kaixin Zhou, , A. Jonsson

This study identifies genetic variants associated with glycaemic response to GLP-1 receptor agonists using observational and trial data, finding variants in GLP-1R and ARRB1 linked to HbA1c reduction.

The Lancet Diabetes & Endocrinology · Dec 15, 2022Peer-reviewedGenetic & Genomic Medicine

Arrhythmic gut microbiome signatures for risk profiling of Type-2 Diabetes

S. Reitmeier, S. Kiessling, T. Clavel, M. List, E. L. Almeida, T. G. Ghosh, K. Neuhaus, M. Troll, H. Grallert, W. Rathmann, B. Linkohr, A. Franke, C. I. Le Roy, J. Bell, T. Spector, , D. Haller

The paper identifies arrhythmic gut microbiome signatures associated with Type-2 Diabetes risk and validates them in a separate cohort.

bioRxiv · Dec 27, 2019Microbiology

Variation in the plasma membrane monoamine transporter (PMAT, encoded in SLC29A4) and organic cation transporter 1 (OCT1, encoded in SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: an IMI DIRECT study

Adem Y. Dawed, Kaixin Zhou, Nienke van Leeuwen, Anubha Mahajan, Neil Robertson, Robert Wilhelm Koivula, Petra J. M. Elders, Simone P. Rauh, Angus G. Jones, Reinhard Walter Holl, Julia Stingl, Paul W. Franks, Mark I. McCarthy, Leen M. ‘t Hart, Ewan R. Pearson, , A. Forman

This study investigates the association between genetic variants in PMAT and OCT1 transporters and metformin gastrointestinal intolerance in type 2 diabetes patients.

Diabetes Care · Mar 18, 2019Peer-reviewedGenetics